SAFETY AND EFFICACY OF INTRA-RENAL ARTERIAL AUTOLOGOUS CD34+CELL TRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE II CLINICAL TRIAL

被引：0
|
作者：
Yang, Chihchao [1 ,2 ]
Li, Yi-Chen [1 ,3 ]
Yip, Honkan [1 ,3 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[2] Chang Gung Univ, Div Nephrol, Dept Internal Med, Coll Med, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0182
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of intrarenal arterial autologousCD34+cell transfusion in patients with chronic kidney disease: A randomized, open-label, controlled phaseIIclinical trial
    Liu, Daniel D.
    Ullah, Mujib
    Concepcion, Waldo
    Dahl, Jeremy J.
    Thakor, Avnesh S.
    STEM CELLS TRANSLATIONAL MEDICINE, 2020, 9 (08) : 850 - 866
  • [2] Efficacy and safety of spironolactone on proteinuria in chronic kidney disease patients in Yaounde: open-label randomized clinical trial
    Ngatchou, N.
    Ashuntantang, G.
    Menanga, A. P.
    Kaze, F. J. Folefack
    Sobngwi, E.
    Kingue, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 : S21 - S22
  • [3] Investigated the safety of intra-renal arterial transfusion of autologous CD34+cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial
    Lee, Mel S.
    Lee, Fan-Yen
    Chen, Yung-Lung
    Sung, Pei-Hsun
    Chiang, Hsin-Ju
    Chen, Kuan-Hung
    Huang, Tien-Hung
    Chen, Yi-Ling
    Chiang, John Y.
    Yin, Tsung-Cheng
    Chang, Hsueh-Wen
    Yip, Hon-Kan
    ONCOTARGET, 2017, 8 (11) : 17750 - 17762
  • [4] Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34+cells for acute ischemic stroke patients-A randomized, open-label, controlled phase II clinical trial
    Lin, Hung-Sheng
    Sung, Pei-Hsun
    Huang, Shu-Hua
    Lin, Wei-Che
    Chiang, John Y.
    Ma, Ming-Chun
    Chen, Yi-Ling
    Chen, Kuan-Hung
    Lee, Fan-Yen
    Ko, Sheung-Fat
    Yip, Hon-Kan
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [5] Investigated the safety of intra-renal arterial transfusion of autologous CD34+cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease
    Yip, H. K.
    Shao, P. L.
    Sung, P. H.
    Chua, S.
    Sheu, J. J.
    Leu, S.
    Wallace, C. G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 539 - 539
  • [6] Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study
    Kawaguchi, Takumi
    Komori, Atsumasa
    Seike, Masataka
    Fujiyama, Shigetoshi
    Watanabe, Hiroshi
    Tanaka, Masatoshi
    Sakisaka, Shotaro
    Nakamuta, Makoto
    Sasaki, Yutaka
    Oketani, Makoto
    Hattori, Toshihiro
    Katsura, Koichi
    Sata, Michio
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (12) : 1342 - 1351
  • [7] Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study
    Takumi Kawaguchi
    Atsumasa Komori
    Masataka Seike
    Shigetoshi Fujiyama
    Hiroshi Watanabe
    Masatoshi Tanaka
    Shotaro Sakisaka
    Makoto Nakamuta
    Yutaka Sasaki
    Makoto Oketani
    Toshihiro Hattori
    Koichi Katsura
    Michio Sata
    Journal of Gastroenterology, 2012, 47 : 1342 - 1351
  • [8] Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase II trial
    Charu, Veena
    Belani, Chandra P.
    Gill, Ahmad N.
    Bhatt, Mukesh
    Tomita, Dianne
    Rossi, Greg
    Ben-Jacob, Ali
    ONCOLOGIST, 2007, 12 (06): : 727 - 737
  • [9] A RANDOMIZED, OPEN-LABEL, SINGLE-CENTER, PHASE II CLINICAL TRIAL TO EXPLORE THE SAFETY AND EFFICACY OF RECOMBINANT HEPATITIS B IMMUNOGLOBULIN
    Song, Gi-Won
    Lee, Sung-Gyu
    Hwang, Shin
    Park, Gil-Chun
    Chung, Yongkyu
    Ha, Su-Min
    Kang, Sang-Hyun
    Lee, Hyoung Uk
    Lee, Yun Hee
    Kwon, Jae-Hyun
    Jwa, Eun-Kyung
    Cho, Hwui-Dong
    TRANSPLANT INTERNATIONAL, 2017, 30 : 231 - 231
  • [10] Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial
    Rastvorceva, Rada M. Grubovic
    Useini, Sedula
    Stevanovic, Milena
    Demiri, Ilir
    Petkovic, Elena
    Franchini, Massimo
    Focosi, Daniele
    LIFE-BASEL, 2022, 12 (10):
12345